Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ischemia Lesions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01200693
What this trial is testing

Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

Who this might be right for
Coronary Artery DiseaseCoronary Stenosis
Catholic University of the Sacred Heart 80
Not applicableEnded earlyNCT04375085
What this trial is testing

DESyne X2 Post Market Follow-up Study

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 49
Post-approval studies (Phase 4)Study completedNCT04808310
What this trial is testing

QUantitative Flow Ratio Or Angiography for the assessMent of nOn-culprit Lesions

Who this might be right for
Coronary Artery Disease
Johannes Gutenberg University Mainz 200
Not applicableStudy completedNCT04680689
What this trial is testing

Assessment of Lesion-Associated Myocardial Ischemia Based on Fusion Coronary CT Imaging

Who this might be right for
Myocardial IschemiaMyocardial ViabilityCoronary Stenosis+1 more
Cardio Med Medical Center 100
Not applicableWithdrawnNCT00895791
What this trial is testing

COmplex BifuRcation Lesions: A Comparison Between the AXXESS Device and Culotte Stenting: An Optical Coherence Tomography (OCT) Study

Who this might be right for
Coronary Artery Stenosis
Universitaire Ziekenhuizen KU Leuven
Not applicableUnknownNCT00715884
What this trial is testing

Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems

Who this might be right for
Coronary Artery DiseaseCoronary Atherosclerosis
Cordis US Corp. 678
Large-scale testing (Phase 3)UnknownNCT00116792
What this trial is testing

PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus
Gold, Herman K., MD 120
Not applicableEnded earlyNCT04052763
What this trial is testing

FFR-CT to Detect the Absence of Hemodynamically Significant Lesions in Patients With High-risk Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Centre Hospitalier Universitaire Vaudois 164
Post-approval studies (Phase 4)Study completedNCT00552669
What this trial is testing

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents

Who this might be right for
Coronary Heart DiseaseCoronary Restenosis
Centro de estudios en Cardiologia Intervencionista 200
Not applicableEnded earlyNCT00777842
What this trial is testing

Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery

Who this might be right for
Coronary Artery Disease
Cook Group Incorporated 19
Not applicableLooking for participantsNCT05669222
What this trial is testing

The FAVOR V AMI Trial

Who this might be right for
ST-Segment Elevation Myocardial InfarctionMultivessel Coronary Artery DiseasePercutaneous Coronary Intervention
China National Center for Cardiovascular Diseases 5,000
Large-scale testing (Phase 3)Study completedNCT00000540
What this trial is testing

Coronary Artery Bypass Graft (CABG) Patch Trial

Who this might be right for
ArrhythmiaCardiovascular DiseasesCoronary Disease+5 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableUnknownNCT05971394
What this trial is testing

IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

Who this might be right for
Infrapopliteal LesionsCritical Limb Ischemia
Biotyx Medical (Shenzhen) Co., Ltd. 100
Not applicableUnknownNCT02775578
What this trial is testing

Optimizing Strategy of Coronary Revascularization in Patients With Multivessel Lesions Combined Heart Failure

Who this might be right for
Heart Failure Due to Coronary Artery Disease
Shanghai Jiao Tong University School of Medicine 525
Large-scale testing (Phase 3)UnknownNCT00471289
What this trial is testing

PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

Who this might be right for
Peripheral Vascular Disease
Netherlands Society for Interventional Radiology 144
Not applicableLooking for participantsNCT04449523
What this trial is testing

Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions

Who this might be right for
Silent StrokeSilent Cerebral InfarctFibrillation
Insel Gruppe AG, University Hospital Bern 150
Not applicableUnknownNCT03505931
What this trial is testing

Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)

Who this might be right for
Symptomatic Peripheral Artery Disease With Femoropopliteal LesionsModerate or Severe Claudication (Rutherford Category 2 or 3)Critical Limb Ischemia (Rutherford Category 4 or 5)
Yonsei University 100
Not applicableLooking for participantsNCT06657833
What this trial is testing

DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.

Who this might be right for
Coronary Artery Disease
Fundación EPIC 128
Not applicableStudy completedNCT02086045
What this trial is testing

Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 126
Large-scale testing (Phase 3)Study completedNCT00322569
What this trial is testing

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Who this might be right for
Coronary Disease
Cordis US Corp. 246
Next Page